12.07.2015 Views

Formulation and Evaluation of Perindopril Sublingual Tablets

Formulation and Evaluation of Perindopril Sublingual Tablets

Formulation and Evaluation of Perindopril Sublingual Tablets

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

International Journal <strong>of</strong> Research in Pharmaceutical <strong>and</strong> Biomedical Sciences ISSN: 2229-3701The prepared tablets in all formulations possessedgood mechanical strength with sufficient hardnessin the range <strong>of</strong> 3.6 to2.8 kg/sq.cm. The tablet meanthickness was almost uniform in all formulations.The thickness varies between 3.9 to 3.8 mm.The friability varies between 0.39 to 0.33 %. Thefriability values between 1% were an indication <strong>of</strong>good mechanical resistance <strong>of</strong> tablets.The drug content in all formulations (F1toF4) washighly uniform <strong>and</strong> in the range <strong>of</strong> 100.87 to 98.82%.The wetting time was found to be in the range <strong>of</strong>132 sec to 45 sec. The water absorption ratio in allformulations (F1toF4) was found to be in the range<strong>of</strong> 55 to 27.It was observed that wetting time <strong>and</strong>water absorption ratio increased as theconcentration <strong>of</strong> crospovidone increased. Thedisintegration time in all formulations wereobserved within fraction <strong>of</strong> second. Thedisintegration time in all formulations (F1toF4) wasfound to be in the range 237 sec to 98 sec. It wasobserved that concentration <strong>of</strong> crospovidoneincreases disintegration time not decreasedsignificantly but the formulation F4, containg 8%crospovidone as superdisintegrant showed fasterdisintegration rate as compared to otherformulations.The in-vitro dissolution studies <strong>of</strong> all formulations(F1toF4) were conducted <strong>and</strong> the results are shownin table 03.The percentage <strong>of</strong> drug release forformulation, F1 was found to be 14.88 % during2min. And maximum percentage <strong>of</strong> drug releasewas found to be 97.01% during 26 min. Thepercentage <strong>of</strong> drug release for formulation, F2 wasfound to be 20.52 % during 2min. And maximumpercentage <strong>of</strong> drug release was found to be 98.51%during 22 min. The percentage <strong>of</strong> drug release forformulation, F3 was found to be 23.13 % during2min. And maximum percentage <strong>of</strong> drug releasewas found to be 97.76 % during 26 min. Thepercentage <strong>of</strong> drug release for formulation, F4 wasfound to be 35.51% during 2min. And maximumpercentage <strong>of</strong> drug release was found to be 99.88 %during12 min .From the above studies, it wasobserved that increase in concentration <strong>of</strong>superdisintegrant i.e. crospovidone, the percentage<strong>of</strong> drug release increased. Among the allformulations (F1toF4) , the best in-vitro drugrelease observed in formulation ,F4 was found tobe 99.88 %, as increase the concentration <strong>of</strong>crospovidone that is due to result <strong>of</strong> rapiddisintegration. During the dissolution studies, itwas observed that the tablets were initially swelled<strong>and</strong> erodible over period <strong>of</strong> time.The in-vitro drug release data <strong>of</strong> all <strong>Perindopril</strong>sublingual tablets were subjected to goodness <strong>of</strong> fittest by linear regression analysis according to Zeroorder equation, Ist order equation, Higuchi’sequation <strong>and</strong> Krosmeyer-Peppas equation toascertain the mechanism <strong>of</strong> drug release. Theresults <strong>of</strong> linear regression analysis includingregression coefficient are presented in table04.Among the regression correlation co-efficient(R 2 ) values <strong>of</strong> Ist order equation was found to behigher, similarly among the Higuchi’s equation <strong>and</strong>Krosmeyer-Peppas equation, the (R 2 ) values <strong>of</strong>Higuchi’s equation was found to be higher .Hencethe drug release followed the Ist order releasekinetics with diffusion mechanism.Table 1: <strong>Formulation</strong> Composition <strong>of</strong> Fast Dissolving<strong>Sublingual</strong> <strong>Tablets</strong> <strong>of</strong> <strong>Perindopril</strong>Ingredients F1 F2 F3 F4<strong>Perindopril</strong> 4 4 4 4Crospovidone 4 8 12 16Sodium saccharine 10 10 10 10Mannitol 85 85 85 85Micro crystalline cellulose 91 87 83 79Talc 3 3 3 3Magnesium stearate 3 3 3 3Table 2: Weight variation, Hardness, Thickness <strong>and</strong>Friability <strong>of</strong> <strong>Perindopril</strong> sublingual tablets<strong>Formulation</strong> codeWeightVariationHardness(kg/cm 2 )Thickness(mm)Friability(% )F1 202.15 3.1 3.9 0.29F2 200.18 2.8 3.7 0.33F3 201.86 3.5 3.8 0.35F4 199.98 3.5 3.8 0.321196Vol. 2 (3) Jul – Sep 2011www.ijrpbsonline.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!